selected publications
-
Reply to P.G. Tsoutsou et al, o. Kaidar-Person et al, and A. Courdi et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2013
Article
GET IT
Times cited: 1 -
Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2013
Academic Article
GET IT
Times cited: 998 -
Phase III double-blind, placebo-controlled, prospective randomized trial of adjuvant tamoxifen vs. tamoxifen and fenretinide in postmenopausal women with positive receptors (EB193): an intergroup trial coordinated by the Eastern Cooperative Oncology Group.
Medical oncology (Northwood, London, England).
2010
Academic Article
GET IT
Times cited: 15 -
Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2008
Information Resource
GET IT
Times cited: 270 - Keeping faith with trial volunteers. Nature. 2007 Academic Article GET IT
-
ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2006
Information Resource
GET IT
Times cited: 166 -
Choosing a child and adolescent psychiatry residency.
Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry.
2006
Information Resource
GET IT
Times cited: 5 -
Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer.
The New England journal of medicine.
2004
Academic Article
GET IT
Times cited: 774 -
Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2003
Academic Article
GET IT
Times cited: 1102 -
Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study--Cancer and Leukemia Group B 8642.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
1999
Academic Article
GET IT
Times cited: 31 -
Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B.
Journal of the National Cancer Institute.
1998
Academic Article
GET IT
Times cited: 475 -
Psychological symptoms and disease-free and overall survival in women with stage II breast cancer. Cancer and Leukemia Group B.
Journal of the National Cancer Institute.
1996
Academic Article
GET IT
Times cited: 88 - Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1996 Academic Article GET IT
-
Leukemogenic potential of adjuvant chemotherapy for early-stage breast cancer: the Eastern Cooperative Oncology Group experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
1995
Academic Article
GET IT
Times cited: 92 -
Combination chemotherapy for metastatic or recurrent carcinoma of the breast--a randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and Leukemia Group B Study 8281.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
1995
Academic Article
GET IT
Times cited: 35 -
Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma.
The New England journal of medicine.
1994
Academic Article
GET IT
Times cited: 623 -
Cytosine arabinoside and cisplatin for advanced breast cancer. A phase II study of the Cancer and Leukemia Group B.
Cancer.
1991
Academic Article
GET IT
Times cited: 10 -
Prediction of prognosis in primary breast cancer by detection of a high molecular weight mucin-like antigen using monoclonal antibodies DF3, F36/22, and CU18: a Cancer and Leukemia Group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
1991
Academic Article
GET IT
Times cited: 69 -
A feasibility study of intensive CAF as outpatient adjuvant therapy for stage II breast cancer in a cooperative group: CALGB 8443.
Cancer investigation.
1990
Academic Article
GET IT
Times cited: 9 -
Arterial thrombosis associated with adjuvant chemotherapy for breast carcinoma: a Cancer and Leukemia Group B Study.
The American journal of medicine.
1989
Academic Article
GET IT
Times cited: 86 -
A randomized trial of CMF versus CMFVP as adjuvant chemotherapy in women with node-positive stage II breast cancer: a CALGB Study.
World journal of surgery.
1985
Academic Article
GET IT
Times cited: 18